Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, April 10, 2015 10:27:44 AM
bullish
recent bounce and a gap up
bull flag breakout
measured move possible
## source: finance.yahoo.com
Mon, 06 Apr 2015 11:14:55 GMT ~ Curis Announces Orphan Drug Designation for CUDC-907 in Diffuse Large B-Cell Lymphoma
[at noodls] - LEXINGTON, Mass., April 6, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of ...
read full: http://www.noodls.com/view/7937B3BF5A704F3B9D220529DBDEDC3ECC65591F
*********************************************************
Mon, 06 Apr 2015 11:00:00 GMT ~ Curis Announces Orphan Drug Designation for CUDC-907 in Diffuse Large B-Cell Lymphoma
[GlobeNewswire] - LEXINGTON, Mass. -- Curis, Inc. , a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, announced today that the U.S. ...
read full: http://finance.yahoo.com/news/curis-announces-orphan-drug-designation-110000603.html
*********************************************************
Mon, 09 Mar 2015 20:28:20 GMT ~ Vista Outdoor Inc (VSTO), Curis, Inc. (CRIS): First Eagle Investment Management’s Latest Bullish Plays
read full: http://www.insidermonkey.com/blog/vista-outdoor-inc-vsto-curis-inc-cris-first-eagle-investment-managements-latest-bullish-plays-340107/
*********************************************************
Tue, 03 Mar 2015 21:27:03 GMT ~ Curis to Present at the 27th Annual Roth Conference
[at noodls] - LEXINGTON, Mass., March 3, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of ...
read full: http://www.noodls.com/view/C39371A41E9758E8B9B8E7DE2EC5D2ACA0DD1507
*********************************************************
Tue, 03 Mar 2015 21:00:00 GMT ~ Curis to Present at the 27th Annual Roth Conference
[GlobeNewswire] - LEXINGTON, Mass. -- Curis, Inc. , a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced that Dr. Mani ...
read full: http://finance.yahoo.com/news/curis-present-27th-annual-roth-210000060.html
*********************************************************
$CRIS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CRIS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CRIS/company-info
Ticker: $CRIS
OTC Market Place: Not Available
CIK code: 0001108205
Company name: Curis, Inc.
Company website: http://www.curis.com
Incorporated In: DE, USA
$CRIS share structure
## source: otcmarkets.com
Market Value: $289,931,456 a/o Apr 09, 2015
Shares Outstanding: l PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"> OTC Markets | Official site of the OTCQX, OTCQB and OTC Pink Marketplaces featuring Free Stock & Bond Quotes, Trade Prices, Chart, Financials and Company News & Information for Investors, Companies and Traders - OTCMarkets.com var appSection = "" ; var tierGroupId = undefined; var symbol = "CRIS"; var jq191 = $.noConflict(true); var appNav = new OTCMarketsAppNav(); var iqCaller = new OtcIQCalls(); var commonCaller = new PinkCommonCalls(); var contentCaller = new PinkContentCalls(); var edgarCaller = new PinkEdgarCalls(); var decorateSymbols = new SymbolDecorator(commonCaller); height="0" width="0" style="display:none;visibility:hidden"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer',"GTM-N65JXN"); OTC Markets Home Marketplaces Market Activity Current Market Closing Summary Broker Dealer Data Corporate Actions Short Sale Data Reg SHO Data News Company News & Financials Press Releases Videos & Presentations RSS Feeds OTC Markets Events OTC Markets Newsletter OTC Markets Press Center Services Companies Investors Market Data Trading Research Stock Screener OTCQX Company List Company Directory Service Provider Directory OTCQX Advisor List Broker Dealer Directory Prohibited Attorney List Symbology Glossary Learn Our Marketplaces Market 101 Investor Protection Reporting Requirements American Depositary Receipts (ADRs) Apply for OTCQX - Our Best Marketplace Comply with New OTCQB Requirements Information for OTC Pink Companies How to Get Traded Caveat Emptor Policy FINRA & SEC Rules Whitepapers FAQs tierTitle = getTierTitle(undefined); Company Directory | Stock Screener OTC Market Totals - Securities - Dollar Volume - Share Volume - Trades var glossaryDecorator = new GlossaryDecorator (contentCaller) ; $('p').each (function () { var glossaryId = $(this).attr('glossaryId'); if (glossaryId) this.psGlossaryId=glossaryId; }); if (document.getElementById('p')) glossaryDecorator .doSection (document.getElementById ('p')); $('#quoteEntry input#quoteBox').focus(function() { toggleFieldValue(this, 'Enter Symbol/Company Name', ''); }).blur(function() { toggleFieldValue(this, '', 'Enter Symbol/Company Name'); }); var security = new SecurityInfo(84466, 637447, "Curis, Inc.", "CURIS INC", "CRIS", "Nasdaq", false, false, undefined, "Common Stock", undefined, undefined, false, false, true, false, 0.010000000000000, "0.01", undefined, false, 1.0, undefined); var symbolSecurity = (security.symbol)? security.symbol:security.secId; var initNewsId = undefined; var glossaryDecorator = new GlossaryDecorator (contentCaller) ; Quote Charts Company Profile News Financials Filings and Disclosure Short Sales Insider Disclosure Research Reports Videos and Presentations CRIS Curis, Inc. Common Stock Nasdaq function doOTCQX30Logo(url) { var CONSTITUENTS_DATA; if ($.browser.msie) { var http = new XDomainRequest(); http.open("get", url); http.onload = function() { var data = http.responseText; if (typeof data === "undefined") return; CONSTITUENTS_DATA = JSON.parse(data); displayIndexLogo(CONSTITUENTS_DATA); }; http.send(null); } else { $.ajax({ type : "GET", url : url, data : {}, success : function(data) { if (typeof data === "undefined") return; CONSTITUENTS_DATA = JSON.parse(data); displayIndexLogo(CONSTITUENTS_DATA); } }); } } function displayIndexLogo(constituents) { if (typeof constituents === undefined) { if (console && console.log) { console.log("Unable to load constituents."); } } var result = $.grep(constituents, function(e){ return e.ticker == security.symbol; }); if (result.length > 0) { $('.tierLogoContainer a').attr('href', '/index/.OTCQX30/quote'); $('.tierLogo').attr('src', '/content/doc/otcm/tier/logo/small/otcqx30.png'); $('.tierLogo').attr('alt','OTCM QX ADR 30 Index Constituent'); $('.tierLogo')[0].psGlossaryId='otcqx30-constituent'; handler.decorateGlossary(); } } var json_url = "http://s3.amazonaws.com/content.otcmarkets.com/constituents/otcqx_30_list.json"; doOTCQX30Logo(json_url); var handler = new QuoteHandler(); handler.checkCaveat(); var tradeHeaderHandler; if (!window.location.href.match('quote')) tradeHeaderHandler = new TradeHeaderHandler(iqCaller, window.document.getElementById('quoteBar')); if (security.symbol == null || security.symbol.length == 0) { $('#quoteUnderArrowTabs li.eqOnly').hide(); } $('img').each(function () { var glossaryId = $(this).attr('glossaryId'); if (glossaryId) this.psGlossaryId = glossaryId; }); handler.decorateGlossary(); $("#title").html('Company Info'); var shortDesc = undefined; var longDesc = undefined; function toggleFullDescription(full) { if (full) { $("#businessContent p").html(longDesc); }else { $("#businessContent p").html(shortDesc); } } Contact Info 61 Moulton Street Cambridge, MA 02138 Website: http://www.curis.com Phone: (617) 503-6500 Business Description Not Available Update Company Profile Financial Reporting/Disclosure Reporting Status U.S. Reporting: SEC Filer
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$CRIS extra dd links
Company name: Curis, Inc.
Company website: http://www.curis.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CRIS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CRIS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CRIS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/news - http://finance.yahoo.com/q/h?s=CRIS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CRIS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CRIS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CRIS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Curis%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Curis%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Curis%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.curis.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.curis.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.curis.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CRIS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001108205&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CRIS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CRIS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CRIS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CRIS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CRIS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CRIS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CRIS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CRIS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CRIS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CRIS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CRIS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CRIS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CRIS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CRIS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CRIS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CRIS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CRIS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CRIS
$CRIS DD Notes ~ http://www.ddnotesmaker.com/CRIS
Recent CRIS News
- Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 • PR Newswire (US) • 04/30/2024 12:00:00 PM
- Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 04/05/2024 11:30:00 AM
- Curis to Present at Upcoming Healthcare Conferences in April • PR Newswire (US) • 04/04/2024 11:30:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:16:14 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/08/2024 09:36:50 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/08/2024 09:27:47 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/08/2024 09:01:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 01:01:02 PM
- Curis Provides Fourth Quarter 2023 Business Update • PR Newswire (US) • 02/08/2024 01:00:00 PM
- Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024 • PR Newswire (US) • 02/01/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 01:13:35 PM
- Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 01/05/2024 01:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 12/21/2023 09:00:47 PM
- Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study • PR Newswire (US) • 12/12/2023 01:00:00 PM
- Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference • PR Newswire (US) • 12/11/2023 01:00:00 PM
- Curis Announces Three Presentations at ASH • PR Newswire (US) • 12/06/2023 01:00:00 PM
- Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma • PR Newswire (US) • 12/05/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 12:03:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 12:01:51 PM
- Curis Provides Third Quarter 2023 Business Update • PR Newswire (US) • 11/02/2023 12:00:00 PM
- Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023 • PR Newswire (US) • 10/26/2023 12:30:00 PM
- Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 10/06/2023 12:56:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/28/2023 08:05:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 12:54:37 PM
- Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer • PR Newswire (US) • 09/12/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM